Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,454.15
-17.35 (-1.18%)
At close: Sep 16, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 152.09 billion as of September 16, 2026. Its market cap has decreased by -12.45% in one year.
Market Cap
152.09B
Enterprise Value
147.78B
Revenue
11.08B
Ranking
n/a
PE Ratio
55.23
Stock Price
1,454.15
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 152.09B, an increase of 54.20%. That is a compound annual growth rate of 15.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 152.09B | 8.04% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |
| AstraZeneca Pharma India | 169.63B |
| Jubilant Pharmova | 162.36B |
| Viyash Scientific | 112.28B |
| Procter & Gamble Health | 89.81B |
| Bliss GVS Pharma | 76.78B |